0.0350CHF-15.46%Mkt Cap: 6.07M $P/E: —Today
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enz…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap6.07M $
Enterprise Value4.69M $
Revenue (TTM)124.97K $
Gross Profit-504.71K $
Net Income (TTM)-7.68M $
Revenue/Share0.0011 USD
Last Price0.0350 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryCH
SectorHealthcare
IndustryBiotechnology
ISINCH0029850754
Valuation
P/E (Trailing)—
P/E (Forward)-0.97
PEG—
EV/EBITDA-1.53
EV/Revenue37.51
P/S53.83
P/B1.39
EPS (TTM)-0.06
EPS (Forward)-0.04
52W Range
0.03107% of range0.0850
52W High0.0850 CHF
52W Low0.0310 CHF
Profitability
Gross Margin0.00%
Oper. Margin-6238.81%
EBITDA Margin0.00%
Profit Margin-22448.44%
ROE-141.15%
ROA-105.72%
Growth
Revenue Growth-89.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.48M $
CapEx (TTM)—
FCF Margin-1392.47%
FCF Yield-28.68%
Net Debt-950.57K $
Net Debt/EBITDA0.31
Balance Sheet
Debt/Equity0.01
Current Ratio0.97
Quick Ratio0.79
Book Value/Sh0.0280 CHF
Cash/Share0.0080 CHF
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CHF
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 26, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.151.90M
Float97.06M
Insiders10.00%
Institutions1.02%
Technical
SMA 500.0418 (-16.3%)
SMA 2000.0479 (-26.9%)
Beta2.00
S&P 52W Chg18.16%
Avg Vol (30d)625.78K
Avg Vol (10d)75.31K
Technical Indicators
RSI (14)50.9
MACD-0.0003
MACD Signal-0.0005
MACD Hist.+0.0002
BB Upper0.0428 CHF
BB Middle0.0407 CHF
BB Lower0.0386 CHF
BB Width10.17%
ATR (14)0.0029 CHF
Vol Ratio (20d)0.33x